Vaccination

US experts convene to decide whether to OK Pfizer vaccine

A U.S. government advisory panel convened on Thursday to decide whether to endorse large-scale use of Pfizer's COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000 Americans.

Vaccination

Increasing HPV vaccine uptake in adolescents

More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.

Diseases, Conditions, Syndromes

Tackling pandemic threats proactively

The marathon of COVID-19 vaccine development has reached the final sprint. Two leading vaccines have proven to protect 95% of vaccinated people from the disease. For the first time we can be confident that vaccines will put ...

Vaccination

How the polio vaccine virus occasionally becomes dangerous

While the world reels from the spread of SARS-CoV2, the new coronavirus behind COVID-19, a much older and previously feared scourge—poliovirus—is close to being completely eradicated. The polio vaccines, developed by ...

HIV & AIDS

Developing effective vaccines against SARS-CoV-2 and HIV

Researchers led by Raghavan Varadarajan, professor at the Molecular Biophysics Unit, Indian Institute of Science (IISc), are working toward developing effective vaccine strategies against two viruses: SARS-CoV-2 and HIV.

Vaccination

Q&A: A COVID-19 vaccine is coming—will it be safe?

In March, at the start of the COVID-19 pandemic, there was a consensus among health care providers and public health officials that a vaccine that provided complete immunity to SARS-CoV-2, the virus that causes COVID-19, ...

page 2 from 22